UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   Form 10-QSB

--------------------------------------------------------------------------------


(Mark one)

   X     Quarterly  Report Under Section 13 or 15(d) of the Securities  Exchange
------   Act of 1934


                For the quarterly period ended September 30, 2003

         Transition Report Under Section 13 or 15(d) of the Securities  Exchange
------   Act of 1934


         For the transition period from ______________ to _____________

--------------------------------------------------------------------------------


                        Commission File Number: 0-49666
                                                -------

                                Strategika, Inc.
        (Exact name of small business issuer as specified in its charter)

       Delaware                                                75-2926439
------------------------                                ------------------------
(State of incorporation)                                (IRS Employer ID Number)

                      No. 6, Yuanquan Road, Wuqing New-Tech
                         Industrial Park, Tianjin, China
            --------------------------------------------------------
                    (Address of principal executive offices)

                              (011) 86-22-82137-254
                       ----------------------------------
                           (Issuer's telephone number)

--------------------------------------------------------------------------------

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. YES X NO --- ---

State the number of shares outstanding of each of the issuer's classes of common
equity as of the latest practicable date: September 29, 2003: 71,998.302.

Transitional Small Business Disclosure Format (check one): YES    NO X
                                                              ---   ---

<PAGE>

                                Strategika, Inc.

              Form 10-QSB for the Quarter ended September 30, 2003

                                Table of Contents


                                                                            Page
                                                                            ----
Part I - Financial Information

  Item 1   Financial Statements                                               2

  Item 2   Management's Discussion and Analysis or Plan of Operation         12

  Item 3   Controls and Procedures                                           19

Part II - Other Information                                                  20

  Item 1   Legal Proceedings                                                 20

  Item 2   Changes in Securities                                             20

  Item 3   Defaults Upon Senior Securities                                   20

  Item 4   Submission of Matters to a Vote of Security Holders               20

  Item 5   Other Information                                                 21

  Item 6   Exhibits and Reports on Form 8-K                                  22


Signatures












                                       1
<PAGE>
<TABLE>
<CAPTION>

Part I - Financial Information

  Item 1- Financial Statements

                        STRATEGIKA, INC. AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS
                 AS OF SEPTEMBER 30, 2003 AND DECEMBER 31, 2002

                                     ASSETS
                                                                                  September 30,     December 31,
                                                                                       2003             2002
                                                                                  -------------    -------------
                                                                                    (Unaudited)        (Audited)
                                                                                  -------------    -------------
<S>                                                                               <C>              <C>
CURRENT ASSETS:
      Cash                                                                        $     850,544    $     302,974
      Accounts receivable - related party, net of allowance for doubtful
          accounts of $12,877 at September 30, 2003 and at December 31,
          2002, respectively                                                          6,550,668        2,562,657
      Other receivables                                                                 188,846          328,491
      Other receivables - related party                                              13,259,172             --
      Current portion of loans receivable - related party                            12,904,473       10,899,102
      Inventories                                                                     2,760,335        4,047,673
                                                                                  -------------    -------------

          Total current assets                                                       36,514,038       18,140,897
                                                                                  -------------    -------------

BUILDINGS, EQUIPMENT AND AUTOMOBILES, net                                            10,085,211       12,757,497
                                                                                  -------------    -------------

OTHER ASSETS:
      Intangible asset, net                                                             364,686          411,094
      Employee advances                                                                 382,173          554,032
      Deposits                                                                        1,633,939        1,934,436
      Loans receivable - related party                                               12,904,473       10,899,102
      Less current portion of loans receivable                                      (12,904,473)     (10,899,102)
                                                                                  -------------    -------------
          Total other assets                                                          2,380,798        2,899,562
                                                                                  -------------    -------------

                      Total assets                                                $  48,980,047    $  33,797,956
                                                                                  =============    =============
                      LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
      Accounts payable                                                            $   1,674,036    $   1,962,068
      Accounts payable - related party                                                  802,449          762,694
      Advances from customers                                                              --             60,439
      Wages and benefits payable                                                         25,646          165,936
      Other taxes payable                                                               228,243          210,788
      Accrued liabilities                                                                  --          1,130,569
      Other payable - related party                                                   1,543,237        2,294,168
      Short term notes payable                                                        6,168,477        6,460,190
      Current portion of long term debt                                                 227,517          263,677
                                                                                  -------------    -------------
          Total current liabilities                                                  10,669,605       13,310,529
                                                                                  -------------    -------------

LONG TERM DEBT, net of current portion                                                     --            446,029
                                                                                  -------------    -------------

                      Total liabilities                                              10,669,605       13,756,558
                                                                                  -------------    -------------

MINORITY INTEREST                                                                     7,663,037        4,009,228
                                                                                  -------------    -------------
SHAREHOLDERS' EQUITY:
      Common stock, $0.001 par value, 260,000,000 shares authorized,
          71,998,302 and 32,503,302 shares issued and outstanding, respectively           6,851                1
      Paid-in-capital                                                                 8,906,492        8,906,492
      Statutory reserve                                                                 399,173          399,173
      Retained earnings                                                              21,345,667        6,730,432
      Stock receivable                                                                   (6,850)            --
      Accumulated other comprehensive income (loss)                                      (3,928)          (3,928)
                                                                                  -------------    -------------
          Total shareholders' equity                                                 30,647,405       16,032,170
                                                                                  -------------    -------------
                      Total liabilities and shareholders' equity                  $  48,980,047    $  33,797,956
                                                                                  =============    =============
</TABLE>

                                       2
<PAGE>
<TABLE>
<CAPTION>

                        STRATEGIKA, INC. AND SUBSIDIARIES

        CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME
         FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002

                                                      Three months ended              Nine months ended
                                                  ---------------------------    --------------------------
                                                         September 30,                   September 30,
                                                  ---------------------------    ---------------------------
                                                      2003           2002            2003           2002
                                                  ------------   ------------    ------------   ------------
                                                  (Unaudited)    (Unaudited)     (Unaudited)    (Unaudited)
                                                  ------------   ------------    ------------   ------------
<S>                                               <C>            <C>             <C>            <C>
REVENUE - RELATED PARTIES                         $ 13,989,470   $  3,359,868    $ 31,775,037   $  7,655,467

COST OF SALES                                        4,309,393      1,568,563      11,338,306      3,296,581
                                                  ------------   ------------    ------------   ------------

GROSS PROFIT                                         9,680,077      1,791,305      20,436,731      4,358,886

SELLING, GENERAL AND  ADMINISTRATIVE EXPENSES          903,778        653,295       2,264,622      2,484,306
                                                  ------------   ------------    ------------   ------------

INCOME FROM OPERATIONS                               8,776,299      1,138,010      18,172,109      1,874,580

OTHER INCOME (EXPENSE)                                  25,676       (246,169)         96,936       (231,641)
                                                  ------------   ------------    ------------   ------------

INCOME BEFORE MINORITY INTEREST                      8,801,975        891,841      18,269,045      1,642,939

MINORITY INTEREST                                    1,760,396        178,368       3,653,810        328,588
                                                  ------------   ------------    ------------   ------------

NET INCOME                                           7,041,579        713,473      14,615,235      1,314,351

OTHER COMPREHENSIVE INCOME
                                                  ------------   ------------    ------------   ------------

COMPREHENSIVE INCOME                              $  7,041,579   $    713,473    $ 14,615,235   $  1,314,351
                                                  ============   ============    ============   ============

Weighted average number of shares outstanding       32,503,302     32,503,302      33,072,996     28,110,446
                                                  ============   ============    ============   ============

Earnings per share, basic and diluted             $       0.22   $       0.02    $       0.44   $       0.05
                                                  ============   ============    ============   ============
</TABLE>


                                       3
<PAGE>
<TABLE>
<CAPTION>

                        STRATEGIKA INC. AND SUBSIDIARIES

                 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
              FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002



                                                     Number        Common       Paid-in      Statutory
                                                   of shares       stock        capital       Reserve
                                                  (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited)
                                                  -----------   -----------   -----------   -----------
<S>                                               <C>           <C>           <C>           <C>
BALANCE, January 1, 2003, audited                   5,000,508   $         1   $ 8,906,492   $   399,173

   Tianshi stock issued to Tianshi shareholders          --           6,850
   6.5 for one shares forward split                27,502,794
   Issuance of common stock to Tianshi
        shareholders due to reorganization         68,495,000
   Cancellation of common stock held by
        Rene Larrave                              (29,000,000)
   Net income
                                                  -----------   -----------   -----------   -----------
BALANCE, September 30, 2003                        71,998,302   $     6,851   $ 8,906,492   $   399,173
                                                  ===========   ===========   ===========   ===========

BALANCE, January 1, 2002, audited                     500,508   $         1   $ 8,906,492   $      --
   (Reflecting the 6.5 to 1 split in 2003)
   Sale of common stock through private
        placement                                   4,500,000
   Net income
                                                  -----------   -----------   -----------   -----------
BALANCE, September 30, 2002                         5,000,508   $         1   $ 8,906,492   $      --
                                                  ===========   ===========   ===========   ===========


                                                                              Accumulated
                                                                                 other
                                                   Retained        Stock     comprehensive
                                                   earnings     receivable   income (loss)     Totals
                                                  (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited)
                                                  -----------   -----------   -----------   -----------

BALANCE, January 1, 2003, audited                 $ 6,730,432   $      --     $    (3,928)  $16,032,170

   Tianshi stock issued to Tianshi shareholders                      (6,850)
   6.5 for one shares forward split
   Issuance of common stock to Tianshi
        shareholders due to reorganization
   Cancellation of common stock held by
        Rene Larrave
   Net income                                      14,615,235                                14,615,235
                                                  -----------   -----------   -----------   -----------
BALANCE, September 30, 2003                       $21,345,667   $    (6,850)  $    (3,928)  $30,647,405
                                                  ===========   ===========   ===========   ===========

BALANCE, January 1, 2002, audited                 $ 5,133,740   $    (3,928)  $    (3,928)  $14,032,377
   (Reflecting the 6.5 to 1 split in 2003)
   Sale of common stock through private
        placement
   Net income                                       1,314,351                                 1,314,351
                                                  -----------   -----------   -----------   -----------
BALANCE, September 30, 2002                       $ 6,448,091   $    (3,928)  $    (3,928)  $15,346,728
                                                  ===========   ===========   ===========   ===========
</TABLE>



Note: All common stock shares reflect shares after the 6.5 to 1 split in 2003.


                                       4
<PAGE>
<TABLE>
<CAPTION>

                        STRATEGIKA, INC. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
              FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002

                                                                                  2003            2002
                                                                              ------------    ------------
                                                                                Unaudited       Unaudited
                                                                              ------------    ------------
<S>                                                                           <C>             <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
       Net income                                                             $ 14,615,235    $  1,314,351
       Adjustments to reconcile net income  to cash
            used in operating activities:
                 Minority interest                                               3,653,810         328,588
                 Depreciation                                                      749,345         502,228
                 Amortization                                                       46,408          30,220
                 Loss (gain) on sale of assets                                       4,366          (1,784)
            (Increase) decrease in assets:
                 Accounts receivable - related party                            (3,988,011)     (7,204,684)
                 Other receivables                                                 139,645     (15,402,047)
                 Other receivables - related party                             (14,067,143)      1,021,303
                 Inventories                                                     1,287,338      (2,065,759)
                 Employee advances                                                 171,859       3,969,311
                 Decrease in deposits                                              300,497         282,755
            Increase (decrease) in liabilities:
                 Accounts payable                                                 (288,032)      1,147,490
                 Accounts payable - related party                                   39,755        (694,105)
                 Advances from customers                                           (60,439)       (511,361)
                 Wages and benefits payable                                       (140,291)     (1,713,937)
                 Other taxes payable                                                17,455         (83,286)
                 Accrued liabilities                                            (1,130,569)     (2,589,620)
                 Other payables - related party                                  2,487,279      12,769,961
                                                                              ------------    ------------
                        Net cash provided by (used in) operating activities      3,838,507      (8,900,376)
                                                                              ------------    ------------
CASH FLOWS FROM INVESTING ACTIVITIES:
       Payments on loans receivable - related party                                807,971       7,211,424
       Increases in loans receivable - related party                            (2,005,371)           --
       Sale (purchase) of assets                                                (1,319,635)      1,178,302
                                                                              ------------    ------------
                        Net cash (used in) provided by investing activities     (2,517,035)      8,389,726
                                                                              ------------    ------------

CASH FLOWS FROM FINANCING ACTIVITIES:
       Borrowings (payments) on short term notes payable                          (291,713)        (65,732)
       Payments on long term debt                                                 (482,189)        681,626
                                                                              ------------    ------------
                        Net cash (used in) provided by financing activities       (773,902)        615,894
                                                                              ------------    ------------

INCREASE IN CASH                                                                   547,570         105,244

CASH, beginning of period                                                          302,974         329,809
                                                                              ------------    ------------

CASH, end of period                                                           $    850,544    $    435,053
                                                                              ============    ============
</TABLE>


NON-CASH FINANCING AND INVESTING ACTIVITIES:
       During the nine months ended September 30, 2003, the Company sold several
            buildings to a related party through a cancellation of other payable
            with the net book value of $3,238,210. The sale resulted in a gain
            of $1,791.

         Non-cash stock issuance in connection with the merger with Tianshi, see
Note 1 for details.



                                       5
<PAGE>

                        STRATEGIKA, INC AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


Note 1 - Summary of significant accounting policies

Background

On August 22, 2003, Strategika,  Inc., a corporation organized under the laws of
the State of Delaware ("STRATEGIKA"); Tianshi International Holdings Group Ltd.,
a  corporation   organized   under  the  laws  of  the  British  Virgin  Islands
("TIANSHI");  Jin Yuan Li, Wen Jun Jiao and Yu Peng Yan,  all Chinese  Nationals
who are  stockholders  of TIANSHI (the "TIANSHI  Stockholders")  entered into an
Agreement  and Plan of  Reorganization  (the  "Agreement").  The  Agreement  was
effective  on  September  9,  2003  (the  "Effective  Date").  Pursuant  to  the
Agreement,  STRATEGIKA received from the TIANSHI  Stockholders all of the issued
and  outstanding  common stock of TIANSHI in exchange for  68,495,000  shares of
restricted  (as defined in Rule 144 of the  Securities  Act of 1993, as amended)
common stock of STRATEGIKA. As additional  consideration,  the 29,000,000 shares
of the common stock of  STRATEGIKA  held by Rene  Larrave,  the sole officer and
director of STRATEGIKA prior to the reorganization,  were redeemed to STRATEGIKA
and dully cancelled by STRATEGIKA.

Pursuant to the Agreement and on the Effective  Date, as  consideration  for the
exchange  of  the  TIANSHI  Shares,   STRATEGIKA  issued  68,495,000  shares  of
restricted  common  capital  stock,  par value $0.001 per share,  to the TIANSHI
Stockholders,  representing  approximately  95% of the  issued  and  outstanding
common capital stock of STRATEGIKA following the time of the issuance. There are
currently  71,998,302  issued  and  outstanding  shares of  common  stock of the
reorganized STRATEGIKA.

STRATEGIKA was incorporated on July 13, 1990 as Super Shops, Inc. under the laws
of the State of Michigan.  In October 2000, Super Shops, Inc.  reincorporated in
Delaware and changed its name to MIA Acquisition  Corp. On February 11, 2002, in
connection with a change in control  transaction,  MIA Acquisition  Corp changed
its name to  Strategika,  Inc.  Until the Effective  Date,  STRATEGIKA  had only
nominal assets and liabilities and was a development stage company attempting to
provide network security services to Fortune 1000 listed companies.  As a result
of the  reorganization,  STRATEGIKA  will  continue the business  operations  of
TIANSHI.

TIANSHI  was  incorporated  on March 24,  2003 in the  territory  of the British
Virgin  Islands.  The following is a description of the various  individuals and
companies discussed in the footnotes and their relationship to TIANSHI.

Tianshi International  Holdings Group Ltd. - British Virgin Island company owned
100% by Li Jinyuan

Li Jinyuan - individual - President and majority shareholder

Li Baolan - individual - Daughter of Li Jinyuan

Tianjin Tianshi  Biological  Development Co., Ltd. - Chinese joint venture which
Tianshi International Holdings Group Ltd. owns 80%

Tianshi Hong Kong International  Development Co., Ltd. - Hong Kong company owned
100% by Li Jinyuan




                                       6
<PAGE>

                        STRATEGIKA, INC AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


Note 1 - Summary of significant accounting policies (continued)

Background (continued)

Tianjin Tianshi Biological  Engineering Co., Ltd. - Chinese company owned 49% by
Li Baolan and 51% by Tianjing Tianshi Group Co., Ltd.

Tianjin  Tianshi  Pharmaceuticals  Co., Ltd. - Chinese  company and the majority
shareholder is Tianjin Tianshi Group Co., Ltd.

Tianjin Tianshi Group Co., Ltd. - Owned 90% by Li Jinyuan and 10% by Li Baolan

On June 18, 2003,  Tianshi  International  Holdings  Group Ltd.  acquired 80% of
Tianjin Tianshi BIOLOGICAL Development Co., Ltd. ("BIOLOGICAL"). Tianjin Tianshi
Biological  Development Co., Ltd. is a foreign investment joint venture which is
incorporated  under the laws of the People's  Republic of China ("PRC") on March
27,  1998.  The original  partners in this joint  venture were Tianshi Hong Kong
International Development Co., Ltd. incorporated in Hong Kong which owned 80% of
the joint venture and Tianjin Tianshi Biological Engineering Co., Ltd, a Chinese
company incorporated in the People's Republic of China which owned the remaining
20% of the joint venture. Tianshi Hong Kong International  Development Co., Ltd.
is owned 100% by Li Jinyuan,  the  Company's  president  and major  shareholder.
Tianjin Tianshi  Biological  Engineering Co., Ltd is 49% owned by Ms. Li Baolan,
the daughter of Li Jinyuan and 51% by Tianjin  Tianshi  Group Co.,  Ltd. On June
18, 2003,  Tianjin Tianshi  Biological  Engineering Co., Ltd transferred its 20%
interest  in  the  joint  venture  for  no   consideration  to  Tianjin  Tianshi
Pharmaceuticals Co., Ltd, a Chinese company in which the majority shareholder is
Tianjin Tianshi Group Co., Ltd. On June 18, 2003, Tianshi International Holdings
Group Ltd. acquired 80% of Tianjin Tianshi Biological  Development Co., Ltd from
Tianshi Hong Kong International Development Co., Ltd. for no consideration. This
transfer was made for no  consideration  since Li Jinyuan is president  and sole
shareholder of both companies.

The reporting entity

The financial  statements in the filings of STRATEGIKA  become those of TIANSHI.
The consolidated financial statements of Strategika,  Inc. and subsidiaries (the
"Company") reflect the activities of its 100% owned subsidiary,  Tianjin Tianshi
International Holdings Group Ltd., and its 80% owned subsidiary, Tianjin Tianshi
Biological  Development  Co.,  Ltd. The  consolidated  financial  statements  of
TIANSHI have been presented as if the acquisition of BIOLOGICAL  occurred at the
beginning  of 2002 due to common  management  and  ownership.  The  consolidated
financial  statements  generally  reflect only the activities of Tianjin Tianshi
Biological  Development  Co.,  Ltd.  at its  cost  since  Tianshi  International
Holdings Ltd., had no operational activities for the nine months ended September
30, 2003 and 2002,  respectively.  Since STRATEGIKA's  continuing operations and
balance sheet are insignificant, a pro forma balance sheet at September 30, 2003
and December 31, 2002 and  statements of  operations  for the periods then ended
are not presented herein.



                                       7
<PAGE>

                        STRATEGIKA, INC AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


Note 1 - Summary of significant accounting policies (continued)

The reporting entity (continued)
--------------------------------

Tianjin Tianshi  Biological  Development Co., Ltd. is a foreign investment joint
venture which is incorporated  under the laws of the People's Republic of China.
BIOLOGICAL is classified as a Foreign  Invested  Enterprise (FIE) in the PRC and
is  subject  to the FIE  laws of the PRC.  BIOLOGICAL  is a  Chinese  registered
limited   liability  company  with  a  legal  structure  similar  to  a  regular
corporation and a limited  liability  company  organized under state laws in the
United  States of America.  The Articles of  Association  provides for a 50 year
term beginning on March 27, 1998 with registered capital of $10,000,000.

TIANSHI owns 80% of its  subsidiary  BIOLOGICAL.  The  remaining 20% is owned by
Tianjin  Tianshi  Pharmaceuticals  Co., Ltd, a Chinese  company and the majority
shareholder of this Chinese company is Tianjin Tianshi Group Co., Ltd.

Foreign currency translation
----------------------------

The reporting currency of the Company is the US dollar.  BIOLOGICAL's  financial
records are maintained and the statutory financial  statements are stated in its
local  currency,  Renminbi  (RMB),  as their  functional  currency.  Results  of
operations  and cash flow are  translated at average  exchange  rates during the
period,  and assets and liabilities are translated at the unified  exchange rate
as quoted by the People's Bank of China at the end of the period.

This quotation of the exchange rates does not imply free  convertibility  of RMB
to other foreign currencies.  All foreign exchange transactions continue to take
place either through the Bank of China or other banks authorized to buy and sell
foreign currencies at the exchange rate quoted by the People's Bank of China.

Approval of foreign currency payments by the Bank of China or other institutions
requires submitting a payment application form together with invoices,  shipping
documents and signed contracts.

Translation  adjustments resulting from this process are included in accumulated
other comprehensive income in the consolidated statement of shareholders' equity
and amounted to $(3,928) at September 30, 2003 and December 31, 2002.

Transaction  gains and losses  that arise from  exchange  rate  fluctuations  on
transactions  denominated in a currency  other than the functional  currency are
included  in the  results of  operations  as  incurred.  These  amounts  are not
material to the consolidated financial statements.





                                       8
<PAGE>

                        STRATEGIKA, INC AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


Note 2 - Condensed financial statements and footnotes

The  interim  consolidated  financial  statements  presented  herein  have  been
prepared by the Company  and include the  unaudited  accounts of the Company and
its subsidiaries.  All significant  inter-company accounts and transactions have
been eliminated in the consolidation.

These  condensed  financial  statements  have been prepared in  accordance  with
generally  accepted  accounting  principles  in the United  States  for  interim
financial  information  and the  instructions  to Form  10-QSB and Article 10 of
Regulation S-X. Certain information and footnote  disclosures  normally included
in  financial   statements  presented  in  accordance  with  generally  accepted
accounting principles have been condensed or omitted.  Management of the Company
believes the disclosures made are adequate to make the information presented not
misleading.  The condensed  consolidated  financial statements should be read in
conjunction with STRATEGIKA'S audited financial statements and TIANSHI's audited
consolidated financial statements for the year ended December 31, 2002 and notes
thereto included in STRATEGIKA's Form 8-K, dated September 24, 2003.

In the opinion of management,  the unaudited  condensed  consolidated  financial
statements   reflect  all  adjustments  (which  include  only  normal  recurring
adjustments)  necessary to present fairly the financial  position of the Company
as of September 30, 2003,  the results of  operations  for the nine months ended
September 30, 2003 and 2002,  respectively.  Interim results are not necessarily
indicative  of full year  performance  because  of the  impact of  seasonal  and
short-term variations.

Note 3 - Inventories

Inventories  are  stated  at the lower of cost or  market  using  the  first-in,
first-out basis and consists of the following:

                                  September 30,   December 31,
                                       2003           2002
                                  -------------   -------------
                                   (Unaudited)      (Audited)
                                  -------------   -------------
Raw material                      $   1,523,878   $   1,765,548
Work-in-progress                        292,284         702,162
Finished goods                          944,173       1,579,963
                                  -------------   -------------
                                  $   2,760,335   $   4,047,673
                                  =============   =============


Note 4 - Supplemental disclosure of cash flow information

No income taxes were paid for the nine months ended September 30, 2003 and 2002,
respectively.  Interest  paid  amounted to $361,050  and  $370,243  for the nine
months ended September 30, 2003 and 2002, respectively.






                                       9
<PAGE>

                        STRATEGIKA, INC AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


Note 5 - Related party transactions

Sales
-----

The Company sells a majority of its products to distributors that are related to
the Company  through common  ownership.  The related party  distributors in turn
market and sell the Company's products to independent  distributors or end users
of the products.

Related party sales amounted to $31,775,037 and $7,655,467 for the periods ended
September 30, 2003 and 2002 which  represent 100% of total sales for the periods
ended  September  30,  2003  and  2002,  respectively.  Related  party  accounts
receivable  related to these sales  amounted to  $6,550,668  and  $2,562,657  at
September 30, 2003 and December 31, 2002, respectively,  net of an allowance for
doubtful accounts of $12,877 and $12,877, respectively.

Other receivables
-----------------

The Company is owed  additional  amounts  classified as other  receivables  from
related  parties  totaling  $13,259,172  and $-0- as of  September  30, 2003 and
December  31, 2002,  respectively.  These  receivables  are  generated  from the
Company  making various cash advances and short term loans and the allocation of
various  expenses to related  parties.  These  transactions  are re-occurring in
nature and are paid off during the year. The Company does not charge interest on
these receivables.

Loans receivable
----------------

The Company is also owed amounts  classified as loans  receivables  from related
parties totaling  $12,904,473 and $10,899,102 as of September 30, 2003 and 2002,
respectively.  Prior to the year ended  December  31,  2000,  TIANSHI  made cash
advances and loans to Tianjin Tianshi Biological  Engineering Co which was a 20%
shareholder  of  TIANSHI  prior to June 2003 and  Tianshi  Economic  Development
Group. In June 2003, Tianjin Tianshi  Biological  Engineering Co transferred its
20% ownership to another  related  party.  However,  the amount owned to TIANSHI
still remained outstanding.

There were three loans  outstanding  as of December  31, 2000 which  amounted to
$4,840,000,  $2,009,773 and  $4,926,936.  Interest is being charged at 5.31% per
annum  beginning  January 1, 2000.  As of September  30, 2003 and 2002 there was
accrued  interest of  $2,379,223  and  $1,945,105,  respectively,  owed on these
loans. In August 2003 the Company entered into a payment schedule to pay off the
loans by December 31, 2003.  Interest income  generated from these loans for the
nine months ended September 30, 2003 and 2002 amounted to $434,118 and $520,220,
respectively.

Accounts payable
----------------

Accounts  payable due to related  parties  amounted to $802,449  and $762,694 at
September  30, 2003 and  December  31, 2002,  respectively.  These  amounts were
generated  from the purchases of raw  materials,  rent expense and the Company's
transportation costs.





                                       10
<PAGE>

                        STRATEGIKA, INC AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


Note 5 - Related party transactions (continued)

Other payables
--------------

The Company also had amounts classified as other payables due to related parties
which  amounted to $1,543,237  and $2,294,168 as of September 30, 2003 and 2002,
respectively.  These  amounts  arose from cash  advances  from related  parties,
management fees due to related parties and various non-operational  transactions
incurred with related parties.

Rent expense
------------

As of January 1, 2003,  the Company had a verbal  agreement  with Tianshi Group,
which is a related  party  through  ownership,  to lease a portion of its office
building and manufacturing facilities. The Company has agreed to pay for certain
expenses of the Tianshi  Group in lieu of a lease  payment.  The amount of these
expenses  paid for the nine months ended  September,  2003 and 2002  amounted to
$317,750 and $121,480,  respectively  and have been expensed in the accompanying
statement  of  operations  under  various  general  and  administrative  expense
accounts.  On June 30, 2003, the Company  entered into a written lease agreement
with Tianshi  Group to pay annual rent on these  facilities at 1% of total gross
revenues.  The term of this agreement is for five years commencing on January 1,
2003. In addition,  the Company is obligated to pay insurance,  maintenance  and
other expenses related to the premises.























                                       11
<PAGE>

Item 2 - Management's Discussion and Analysis of Financial Condition and Results
         of Operation


Forward-Looking Statements:

The following  discussion  of the financial  condition and results of operations
should be read in conjunction  with the  consolidated  financial  statements and
related  notes  thereto.  The  following  discussion  contains   forward-looking
statements.  Tianshi International  Holdings Group Limited is referred to herein
as "we" or "our." The words or phrases  "would be," "will allow,"  "intends to,"
"will likely  result,"  "are expected to," "will  continue,"  "is  anticipated,"
"estimate,"   "project,"  or  similar   expressions  are  intended  to  identify
"forward-looking  statements"  Such  statements  include  those  concerning  our
expected  financial  performance,  our corporate strategy and operational plans.
Actual   results   could  differ   materially   from  those   projected  in  the
forward-looking  statements as a result of a number of risks and  uncertainties,
including:  (a) those  risks  and  uncertainties  related  to  general  economic
conditions in China,  including regulatory factors that may affect such economic
conditions; (b) whether we are able to manage our planned growth efficiently and
operate profitable operations,  including whether our management will be able to
identify,  hire, train,  retain,  motivate and manage required personnel or that
management  will  be  able to  successfully  manage  and  exploit  existing  and
potential market  opportunities;  (c) whether we are able to generate sufficient
revenues or obtain financing to sustain and grow our operations; and (d) whether
we are able to successfully  fulfill our primary requirements for cash which are
explained below under "Liquidity and Capital  Resources.  Statements made herein
are as of the date of the  filing  of this Form  10-Q  with the  Securities  and
Exchange  Commission  and should not be relied upon as of any  subsequent  date.
Unless  otherwise  required  by  applicable  law,  we do not  undertake,  and we
specifically disclaim any obligation,  to update any forward-looking  statements
to reflect  occurrences,  developments,  unanticipated  events or  circumstances
after the date of such statement.




                                       12
<PAGE>

OVERVIEW

On August 22, 2003, Strategika,  Inc., a corporation organized under the laws of
the State of  Delaware  ("Strategika");  Tianshi  International  Holdings  Group
Limited,  a corporation  organized  under the laws of the British Virgin Islands
("TIANSHI");  Jin Yuan Li, Wen Jun Jiao and Yu Peng Yan,  all Chinese  Nationals
who are  stockholders  of TIANSHI (the "TIANSHI  Stockholders")  entered into an
Agreement  and Plan of  Reorganization  (the  "Agreement").  The  Agreement  was
effective  on  September  9,  2003  (the  "Effective  Date").  Pursuant  to  the
Agreement,  Strategika received from the TIANSHI  Stockholders all of the issued
and  outstanding  common stock of TIANSHI in exchange for  68,495,000  shares of
restricted  (as defined in Rule 144 of the  Securities  Act of 1993, as amended)
common stock of Strategika. As additional  consideration,  the 29,000,000 shares
of the common stock of  Strategika  held by Rene  Larrave,  the sole officer and
director of Strategika prior to the reorganization,  were redeemed to Strategika
and dully cancelled by Strategika.

Pursuant to the Agreement and on the Effective  Date, as  consideration  for the
exchange of the TIANSHI Shares,  Strategika issued 68,495,000  restricted common
capital  stock,  par  value  $0.001  per  share,  to the  TIANSHI  Stockholders,
representing  approximately  95% of the issued and  outstanding  common  capital
stock of  Strategika  following  the time of the  issuance.  There are currently
71,998,302  issued and  outstanding  shares of common  stock of the  reorganized
Strategika.

Strategika was incorporated on July 13, 1990 as Super Shops, Inc. under the laws
of the State of Michigan.  In October 2000, Super Shops, Inc.  reincorporated in
Delaware and changed its name to MIA Acquisition  Corp. On February 11, 2002, in
connection with a change in control  transaction,  MIA Acquisition  Corp changed
its name to  Strategika,  Inc.  Until the Effective  Date,  Strategika  had only
nominal assets and liabilities and was a development stage company attempting to
provide network security services to Fortune 1000 listed companies.  As a result
of the  reorganization,  Strategika  will  continue the business  operations  of
TIANSHI.

TIANSHI  was  incorporated  on March 24,  2003 in the  territory  of the British
Virgin  Islands.  On June 18,  2003,  TIANSHI  acquired  80% of Tianjin  Tianshi
Biodevelopment  Co.  Limited  ("Tianshi  China") which  conducts  TIANSHI's main
business  operations.  Tianshi  China  is a  foreign  investment  joint  venture
incorporated  in the  People's  Republic of China  ("PRC") on March 27,  1998. A
joint venture agreement was subsequently signed on July 13, 1998 between Tianshi
(HK) International  Limited ("HKCo."),  a company  incorporated in Hong Kong and
100% owned by Mr. Jin Yuan Li; and Tianjin Tianshi  Biological  Engineering Co.,
Limited ("Tianshi  Engineering"),  a Chinese companies 49% owned by Mr. Jin Yuan
Li's  daughter Ms. Bao Lan Li and 51% owned by Tianjin  Tianshi  Group Co., Ltd.
("Tianshi  Group").  Tianshi  Group is a company  organized  under the PRC laws,
located  in  Tianjin,  PRC and 90% owned by Mr. Jin Yuan Li and 10% owned by Ms.


                                       13
<PAGE>

Bao Lan Li. Tianshi China is classified as a Foreign  Invested  Enterprise (FIE)
in the PRC and is subject  to the FIE laws of the PRC.  Its legal  structure  is
similar to a corporation and a limited  liability  company organized under state
laws in the United States. The Articles of Association  provide for a term of 50
years and registered  capital of $10,000,000.  Tianshi China was 80% owned by HK
Co., and 20% owned by Tianshi  Engineering.  On June 18, 2003,  TIANSHI acquired
80%  ownership in Tianshi  China from HK Co. The  remaining  20% was acquired by
Tianjin Tianshi  Pharmaceuticals Co., Ltd., a Chinese company with Tianshi Group
as its majority shareholder (51%).

Tianshi  China is engaged in the  manufacturing  and  production  of  healthcare
products and is based in Tianjin, PRC. Tianshi China is primarily engaged in the
research,  development,  manufacturing  and  marketing  of  healthcare  products
including  herbal products,  vitamin and mineral  supplements and personal care.
Since its establishment,  Tianshi China has developed 7 major product series and
produced  45 types  of  healthcare  products.  27 of them  are  healthcare  food
products,  all of which have obtained the "Health Food  Certificates"  issued by
the PRC  Ministry of Health to be sold in the PRC.  The 7 major  product  series
are: High-Calcium Series, Immune System Adjustment Series,  Nutrient Supplements
Series,  Cholesterol  Adjustment  Series,  High-Fiber  Series,  Heart  and Brain
Improvement  Series and Personal  Care Series.  Under the  High-Calcium  series,
Tianshi  China  has   conducted   extensive   research  and  developed   Tianshi
Hyperclycemia  High Calcium  Nutrient  Powder and Tianshi  Children High Calcium
Nutrient  Powder,  which  have been  awarded  patents  from  State  Intellectual
Properties  Office in China with respective  patent numbers of ZL97115067.2  and
ZL97115068.0.

Tianshi China has its own research and product  development  center.  It employs
professionals in research,  product  development and innovation.  On November 3,
2002,  Tianshi China was awarded Quality System  Certificate for compliance with
the standard  "ISO9001:2000"  in the area of Design and Development,  Production
and Service of Food and Healthcare Food in China.

Tianshi  China has been  conducting  the  marketing  and  sales of its  products
through its affiliate company, Tianshi Engineering in China. Tianshi Engineering
is a limited  liability  company  duly  incorporated  under the laws of PRC, and
affiliated  with  Tianshi  China  through  common  ownership of Mr. Jin Yuan Li.
Tianshi  Engineering  markets and sells Tianshi  China's  products  domestically
through its 22 branches, representative offices and chain stores and 14 domestic
affiliate  companies.  The Company also markets its products to approximately 90
countries  worldwide  including the United States,  South Korea,  Japan,  India,
Thailand,  Malaysia,   Indonesia,  Canada,  Peru,  Brazil,  Russia,  Kazakhstan,
Belarus,  Mongolia,  Finland,  Lithuania,  Britain,  Germany,  France,  Romania,
Ukraine, Portugal, Turkey, Italy, Nigeria, Ghana, South Africa and Australia.



                                       14
<PAGE>

RESULTS OF OPERATIONS

General Results of Operations for the nine months ending September 30, 2003

As of  September  30,  2003,  we had  $21,345,667  of retained  earnings.  As of
September  30, 2003,  we had cash of $850,544 and reported  total  shareholders'
equity of  $30,647,405.  For the nine months  ending  September 30, 2003, we had
revenues  of  $31,775,037  and  general,  administrative  and sales  expenses of
$2,264,622.

1) SALES increased by $24,119,570, or approximately 315.06%, from $7,655,467 for
the nine months  ended  September  30, 2002 to  $31,775,037  for the nine months
ended September 30, 2003. The 315.06% increase was results of directly marketing
our products  international  at the end of 2002. By the end of 2003, we sold our
products to approximately 90 countries.  In addition,  we increased our domestic
networking sales forces during 2003.


2) COST OF GOODS SOLD.  Consolidated cost of goods sold increased by $8,041,725,
from  $3,296,581 for the nine months ended September 30, 2002 to $11,338,306 for
the nine months ended  September 30, 2003. Cost of goods sold as a percentage of
sales  decreased to 35.68% for the nine months ended  September  30, 2003,  from
43.06% for the nine months ended  September  30,  2002.  The decrease in cost of
goods sold as a percentage of sales was a result of stronger  management control
over (1) cost of raw material  purchases;  (2)  utilization  of raw material and
production cost efficiency of production cost; and (3) products quality control.


(3) GROSS  PROFIT.  Consolidated  gross profit  increased by  $16,077,845,  from
$4,358,886 for the nine months ended  September 30, 2002 to $ 20,436,731 for the
nine months  ended  September  30, 2003.  Gross profit as a percentage  of sales
increased to 64.32% for the nine months ended September 30, 2003 from 56.94% for
the nine months ended  September  30, 2002.  This  increase in gross profit as a
percentage  of sales was the results of  increasing  sales both in domestic  and
worldwide and management control on production cost.

(4) SELLING AND ADMINISTRATIVE  EXPENSES.  Selling and  administrative  expenses
decreased by $219,684,  from  $2,484,306 for the nine months ended September 30,
2002 to $2,264,622 for the nine months ended September 30, 2003. The selling and
administrative expenses as a percentage of sales decreased to 7.12% for the nine
months ended  September 30, 2003 from 32.45% for the nine months ended September
30,  2002.The  decrease in selling and  administrative  expenses were due to the
decrease  in the cost of selling  expenses  and related  selling  administrative
expense. At the end of 2002, in order to monitor our production's  manufacturing
and selling  functions,  our management decided to divide all the sales division
to our affiliated company. In results, all the expenses related to sales reduced
tremendously  for the nine  months  ended of 2003  comparing  to the same period
ended 2002.


                                       15
<PAGE>

(5)  NET  INCOME.   Consolidated  net  income   increased  by  $13,300,884,   or
approximately 1,031.27%, from $1,314,351 for the nine months ended September 30,
2002 to $14,615,235  for the nine months ended September 30,, 2003. The increase
was mainly due to  increase  in sales and  decrease  in  production  cost and in
selling and administrative expenses our operation.

CERTAIN RELATIONSHIP AND RELATED TRANSACTIONS

TIANSHI markets most of its products through various domestic and  international
business  entities that are related to Tianshi China through  common  ownership.
Related  party  sales  amounted  to  100%  of  total  sales.  Due to the  common
ownership, there are no formal sales or administrative agreement between Tianshi
China and those related  parties.  The business  operations  among these related
entities are regulated  through  internal  ordinances.  For the domestic market,
Tianshi China sells part of its products to Tianshi  Engineering,  which in turn
sells  them  through  its 22  representative  offices,  and 12 other  affiliated
companies in China. All of these  affiliated  companies are owned in whole or in
part by Jin Yuan Li.

The Company is owed  additional  amounts  classified as other  receivables  from
related  parties  totaling  $13,259,172  and $-0- as of  September  30, 2003 and
December  31, 2002,  respectively.  These  receivables  are  generated  from the
Company  making various cash advances and short term loans and the allocation of
various  expenses to related  parties.  These  transactions  are re-occurring in
nature and are paid off during the year. The Company does not charge interest on
these receivables.


The Company is also owed amounts  classified as loans  receivables  from related
parties  totaling  $12,904,473  and  $10,899,102  as of  September  30, 2003 and
December  31,  2002,  respectively.  Prior to the year ended  December 31, 2000,
Tianshi made cash advances and loans to Tianjin Tianshi  Biological  Engineering
Co  which  was a 20%  shareholder  of  Tianshi  prior to June  2003 and  Tianshi
Economic  Development  Group.  In September  2003,  Tianjin  Tianshi  Biological
Engineering Co transferred its 20% ownership to another related party.  However,
the amount owned to Tianshi still remained outstanding.


                                       16
<PAGE>

There were three loans  outstanding  as of December  31, 2000 which  amounted to
$4,840,000,  $2,009,773 and  $4,926,936.  Interest is being charged at 5.31% per
annum beginning  January 1, 2000. As of September 30, 2003 and December 31, 2002
there was accrued  interest of $ 436,525  and $ 521,083,  respectively,  owed on
these loans. In August 2003 the Company  entered into a payment  schedule to pay
off the loans by December 31, 2003.

Accounts payable due to related parties amounted to $802,449 and $762,694 at
September 30, 2003 and December 31, 2002, respectively. These amounts were
generated from the purchases of raw materials and the Company's transportation
costs.

The Company also had amounts classified as other payables due to related parties
which  amounted to $1,543,237  and $2,294,168 as of September 30, 2003 and as of
December 31, 2002,  respectively.  These  amounts  arose from cash advances from
related   parties,   management   fees  due  to  related   parties  and  various
non-operational transactions incurred with related parties.


As of January 1, 2003,  the Company had a verbal  agreement  with Tianshi Group,
which is a related  party  through  ownership,  to lease a portion of its office
building and manufacturing facilities. The Company has agreed to pay for certain
expenses of the Tianshi  Group in lieu of a lease  payment.  The amount of these
expenses  paid for the nine months ended  September,  2003 and 2002  amounted to
$317,750 and $121,480,  respectively  and have been expensed in the accompanying
statement  of  operations  under  various  general  and  administrative  expense
accounts.  On June 30, 2003, the Company  entered into a written lease agreement
with Tianshi  Group to pay annual rent on these  facilities at 1% of total gross
revenues.  The term of this agreement is for five years commencing on January 1,
2003. In addition,  the Company is obligated to pay insurance,  maintenance  and
other expenses related to the premises.



LIQUIDITY AND CAPITAL RESOURCES

For the nine months ended  September  30, 2003,  net cash  provided by operating
activities was $3,838,507, net cash used in investing activities was $2,517,035,
and net cash used in financing activities was $773,902.

For the nine  months  ended  September  30,  2002,  net cash  used in  operating
activities  was  $8,900,376,  net cash  provided  by  investing  activities  was
$8,389,726, and net cash provided by financing activities was $615,894.



                                       17
<PAGE>

Net cash provided by operating activities increased by $12,738,883 to $3,838,507
for the nine  months  ended  September  30,  2003,  representing  a increase  of
approximately  143.13%  compared  to  $8,900,376  net  cash  used  in  operating
activities for the same period of 2002. The increase in cash flow from operating
activities  primarily reflects  increasing in revenues for the nine months ended
September  30,  2003.  This  increase was also due to our better  management  on
collection of accounts receivable during this year.

Net cash used in investing activities increased by $10,906,761 to $2,517,035 for
the nine months ended  September  30,  2003,  representing  a 130.00%  increase,
compared to $8,389,726  net cash provided by investing  activities  for the same
period of 2002. The increase in net cash used in investing activities was due to
increase  other  receivable  to related  party and increase in purchase  capital
assets.

Net cash used in financing  activities  increased by  $1,389,796 to $773,902 for
the nine months ended  September  30,  2003,  representing  a 225.66%  increase,
compared to $615,894  net cash  provided in  financing  activities  for the same
period of 2002.  The increase in cash used in  financing  was  primarily  due to
decrease in borrowings  from banks and increase in payments on long term debt to
banks.

Going forward,  our primary  requirements for cash consist of: (1) the continued
implementation  of existing  products and general overhead and personnel related
expenses to support these activities; (2) continued promotional networking sales
activities  pertaining to our attempt to increase related revenues;  and (3) the
development costs of our new products.  We anticipate that our current operating
activities will enable us to meet the anticipated cash requirements for the 2003
fiscal year.



MANAGEMENT ASSUMPTIONS.

Management anticipates,  based on internal forecasts and assumptions relating to
our operations  that existing cash and funds  generated from  operations will be
sufficient to meet working capital and capital  expenditure  requirements for at
least the next 12 months. In the event that plans change, our assumptions change
or prove  inaccurate  or if other  capital  resources  and  projected  cash flow
otherwise prove to be  insufficient  to fund  operations  (due to  unanticipated
expense,  technical  difficulties,  or otherwise),  we could be required to seek
additional  financing.  There can be no assurance that we will be able to obtain
additional financing on terms acceptable to it, or at all.


                                       18
<PAGE>

EFFECTS OF INFLATION

We are subject to commodity  price risks arising from price  fluctuations in the
market  prices of the various raw materials  that  comprise our products.  Price
risks are managed by each business unit through  productivity  improvements  and
cost-containment  measures.  Management  does not believe that inflation risk is
material to our  business or our  consolidated  financial  position,  results of
operations or cash flows.

EFFECT OF FLUCTUATION IN FOREIGN EXCHANGE RATES

Our  operating  subsidiaries  are located in China.  This  company  buys all raw
materials in China and sells 50% of our products in China using Chinese Renminbi
as the functional currency.  Based on China government  regulation,  all foreign
currencies  under the  category  of current  accounts  are  allowed to be freely
exchanged with hard  currencies.  During the past two years of operation,  there
were no significant changes in exchange rates; however,  unforeseen developments
may cause a significant change in exchange rates.



Item 3 - Controls and Procedures

As required by Rule 13a-15 under the Exchange  Act,  within the 90 days prior to
the filing date of this report,  the Company  carried out an  evaluation  of the
effectiveness of the design and operation of the Company's  disclosure  controls
and  procedures.  This evaluation was carried out under the supervision and with
the participation of the Company's management, including the Company's President
and Financial Officer.  Based upon that evaluation,  the Company's President and
Financial  Officer  concluded  that  the  Company's   disclosure   controls  and
procedures  are  effective.  There  have  been  no  significant  changes  in the
Company's  internal  controls or in other  factors,  which  could  significantly
affect  internal  controls  subsequent  to the date the Company  carried out its
evaluation.

Disclosure  controls and procedures are controls and other  procedures  that are
designed to ensure that information  required to be disclosed in Company reports
filed or submitted under the Exchange Act is recorded, processed, summarized and
reported,  within the time  periods  specified  in the  Securities  and Exchange
Commission's  rules and  forms.  Disclosure  controls  and  procedures  include,
without limitation,  controls and procedures designed to ensure that information
required to be  disclosed  in Company  reports  filed under the  Exchange Act is
accumulated and  communicated to management,  including the Company's  President
and  Financial  Officer as  appropriate,  to allow  timely  decisions  regarding
required disclosure.


                                       19
<PAGE>

Part II - Other Information

Item 1 - Legal Proceedings

         None

Item 2 - Changes in Securities

Pursuant to the Agreement and Plan of Reorganization  between  Strategika,  Inc.
and TIANSHI  Stockholders  and on the Effective Date, as  consideration  for the
exchange  of  the  TIANSHI  Shares,   STRATEGIKA  issued  68,495,000  shares  of
restricted  common  capital  stock,  par value $0.001 per share,  to the TIANSHI
Stockholders,  representing  approximately  95% of the  issued  and  outstanding
common capital stock of STRATEGIKA following the time of the issuance. There are
currently  71,998,302  issued  and  outstanding  shares of  common  stock of the
reorganized STRATEGIKA.

Item 3 - Defaults on Senior Securities

         None

Item 4 - Submission of Matters to a Vote of Security Holders

The  Company  has held no  regularly  scheduled,  called or special  meetings of
shareholders during the quarterly period ended September 30, 2003.

The  Company  filed an  information  statement  on Form  14C on July  15,  2003,
announcing that the Company had received  written  consents in lieu of a meeting
from stockholders  representing  approximately 89% of our outstanding  shares of
common  stock  approving an amendment of our  Certificate  of  Incorporation  to
effect an increase of our authorized common capital stock from 40 million to 250
million shares.


Item 5 - Other Information

         None



                                       20
<PAGE>

Item 6 - Exhibits and Reports on Form 8-K


         Exhibits

         31.1     Certification  Pursuant to Section  302 of the  Sarbanes-Oxley
                  Act of 2002

         32.1     Certification  Pursuant to Section  906 of the  Sarbanes-Oxley
                  Act of 2002

A report on From 8-K was filed on July 1, 2003, announcing that Strategika, Inc.
has elected not to pursue the  combination  transaction  with Capital  Financial
Group, Inc. as originally reported on February 14, 2003.

A report on Form 8-K was filed on September 24, 2003,  announcing  the change of
control of the Company,  the consummation of the  reorganization  of Strategika,
Inc.  and the merger  with  Tianshi  International  Holdings  Group  Limited,  a
corporation organized under the laws of the British Virgin Islands, the election
of new directors and the change of the Company's  certifying  accountant from SW
Hatfield to Moore  Stephens  Wurth Frazer and Torbet,  LLP, with address at 1199
South Fairway Drive, 2nd Floor,  Walnut,  California  91789. This report on Form
8-K also  released the audited  financial  statements  of Tianshi  International
Holdings Group Limited and its subsidiaries for 2001 and 2002.

Subsequently  a report on Form 8-K/A was filed on October 24,  2003,  conforming
and updating the report on Form 8-K filed on September 24, 2003.

















                                       21
<PAGE>

                                   SIGNATURES

In accordance with the  requirements of the Exchange Act, the registrant  caused
this  report to be  signed on its  behalf  by the  undersigned,  thereunto  duly
authorized.

                                            Strategika, Inc.

Dated: November 12, 2003                      /s/ LI Jinyuan
       --------------                       ------------------------------------
                                            LI Jinyuan
                                            Chairman and President






















                                       22